French Real Estate Stock News

If you are eyeing Bouygues and wondering whether now is the time to buy, sell, or just hold, you are not alone. With every upswing and dip, investors want to know what is really driving this stock, and is it still a bargain? Over the past year, Bouygues has delivered an impressive performance. The stock is up 8.4% in just the past week, 11.2% over the last month, and an astonishing 43.1% for the year to date. Looking back even further, returns have compounded to 77.7% over three years and...

If you own Carrefour stock or you’re thinking about jumping in, you might be wondering what’s next for this retail heavyweight. Over the past month, Carrefour’s share price has climbed a sturdy 10.1%, putting a spring in the step of anyone watching for signs of growth. Even over the past week, the stock notched up another 3.3%. Despite these recent gains, the stock is still down 2.3% so far this year and trails by 4.0% over the last twelve months. Looking further back, there is a respectable...

MedinCell (ENXTPA:MEDCL) shares drew attention after the U.S. FDA cleared UZEDY, its long-acting risperidone injection, for use as a monthly treatment in adults with bipolar I disorder. This marks an added approval beyond schizophrenia. See our latest analysis for MedinCell. MedinCell’s share price has surged recently, booking a 64.2% gain over the past month and notching a remarkable 111.9% share price return in the last 90 days. Momentum clearly accelerated since the FDA expanded UZEDY’s...

Christian Dior SE recently reported that organic revenue grew 1% in the third quarter of 2025, while revenue for the first nine months was €58.09 billion, down from €60.75 billion in the same period last year. This turnaround in quarterly organic revenue, especially following earlier declines and improvement in sales in regions including China, has prompted renewed optimism about the outlook for European luxury goods. We'll explore how Dior's third-quarter return to growth shapes the...

In the past week, EssilorLuxottica reported third-quarter 2025 consolidated revenue of €6.87 billion, up 11.7% year-on-year at constant exchange rates, marking its strongest quarterly performance since its formation. This growth was driven by exceptional demand for its AI-powered smart glasses developed with Meta, alongside recent expansion into AI-based eye health solutions through acquisitions such as Optegra and RetinAI. Let's explore how the accelerating adoption of AI-powered eyewear...

Stock pickers are generally looking for stocks that will outperform the broader market. And while active stock picking...

Key Insights L.D.C's estimated fair value is €181 based on 2 Stage Free Cash Flow to Equity Current share price of...

Pernod Ricard SA ( EPA:RI ) will pay a dividend of €2.35 on the 26th of November. The dividend yield will be 5.3% based...

To the annoyance of some shareholders, The Blockchain Group ( EPA:ALCPB ) shares are down a considerable 41% in the...

Embention Sistemas Inteligentes, S.A.'s ( EPA:MLUAV ) price-to-sales (or "P/S") ratio of 11.7x may look like a poor...

Unfortunately for some shareholders, the EKINOPS S.A. ( EPA:EKI ) share price has dived 42% in the last thirty days...

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things...

Rexel reported third-quarter 2025 sales of €4.76 billion, representing 3% same-day growth, with strong contributions from high-growth sectors in North America, while reconfirming its full-year guidance for slightly positive sales growth, profitability, and cash flow. Additionally, the Board appointed Robert Schuchna, partner at Cevian Capital, as a non-independent member following a recommendation from Cevian, which owns about 23% of Rexel’s share capital. We'll assess how Rexel’s...

Alstom SA recently announced that Martin Sion will take over as Group Chief Executive Officer from April 2026, succeeding long-serving CEO Henri Poupart-Lafarge, with continuity ensured through a planned leadership transition period. Martin Sion brings decades of engineering and executive experience from the aerospace and defense sectors, which could introduce new perspectives to Alstom's leadership during a period of operational transformation. We will explore how the appointment of Martin...

Abivax recently announced new Phase 3 clinical data for obefazimod at the United European Gastroenterology Meeting, showing the therapy achieved clinically meaningful improvements in moderate-to-severely active ulcerative colitis and met its FDA primary endpoints for clinical remission at week 8 in both pivotal ABTECT trials. Additional safety findings highlighted a favorable profile with no new serious infection or malignancy signals across a large and diverse patient population, including...

If you have been watching Christian Dior's share price recently, you probably noticed some interesting moves. In just the past 30 days, the stock climbed 16.4%, a strong rally that might turn heads even if you have been following the broader luxury sector. Over the past week alone, Dior notched a 6.0% gain, showing renewed confidence or perhaps a change in market sentiment around the brand. That said, when we zoom out, the year-to-date return is still down 6.7%, and the one-year return sits...

FDJ United recently confirmed its full-year 2025 earnings guidance, projecting annual revenue to exceed €3.7 billion despite a slight revenue decline anticipated in the fourth quarter compared to the previous year. This guidance comes as the company faces revenue pressure in its Online Betting & Gaming segment from higher taxation and regulatory headwinds, with accelerated cost reduction initiatives forming a key part of its multi-year performance plan. We’ll examine how FDJ United’s...

Sartorius Stedim Biotech S.A. ( EPA:DIM ) led the ENXTPA gainers with a relatively large price hike in the past couple...

Despite an already strong run, Catering International & Services Société Anonyme ( EPA:ALCIS ) shares have been...

Gecina (ENXTPA:GFC) has seen its share price dip about 1% today, a move that stands out given the company's performance this month. Investors seem curious about recent market shifts and what they might signal for the stock's outlook. See our latest analysis for Gecina. After several months of choppy trading, Gecina’s recent 1% slip comes as momentum continues to cool. Its 30-day share price return sits at -4.5%, and the total shareholder return over the last year is down more than 18%. While...

Exail Technologies ( EPA:EXA ) shareholders won't be pleased to see that the share price has had a very rough month...

While EKINOPS S.A. ( EPA:EKI ) might not have the largest market cap around , it received a lot of attention from a...

Key Insights Given the large stake in the stock by institutions, Teleperformance's stock price might be vulnerable to...

Earlier this week, Nexans S.A. announced a sudden leadership transition, with Julien Hueber appointed as Chief Executive Officer effective immediately, succeeding Christopher Guérin, who will remain available for the transition until October 31, 2025. This rapid executive change signals a fresh direction for the company, as the Board seeks to generate new momentum while building on recent achievements in sustainable electrification. We'll explore how Julien Hueber's appointment as CEO could...